Dr. Fisher has over fourteen years experience with the research and development of new drug products. Following a doctorate in synthetic organic chemistry from the University of Melbourne in Australia, he completed his post doctoral research in medicinal chemistry at SmithKline and French (1989), in the US. From there followed a career in the development of new drug products first with SmithKline (1989 - 1994), with Johnson and Johnson (1994 - 1997), and subsequently with small pharmaceutical development companies.
As an independent consultant to emerging pharmaceutical companies he has extensive experience in advising upon, supporting, implementing, and managing all chemistry related activities required to move products into and through the international regulatory drug development process. Through direct involvement with the drug synthesis, analytical chemistry and product formulation processes, Dr. Fisher effectively manages all aspects of the CM&C section required to complete the chemical development of an NCE. His ability to execute in this area is illustrated in his success in taking a new oncolytic agent from the research bench to commencement of human trials in under 18 months, without negative CM&C related comments during the FDA IND review. Through his extensive knowledge of CM&C requirements Dr. Fisher's specializes in identifying superior contractors to complete the specific tasks necessary to advance new chemicals through development.
Finally Dr. Fisher is highly skilled in bringing together the information from all of the outsourced companies to seamlessly compile the documentation required for filing with the regulatory agencies.

Site created and maintained by Opposable Thumb Digital.